Primary sclerosing cholangitis
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Primary sclerosing cholangitis is a condition that affects the bile ducts. These ducts carry bile (a fluid that helps to digest fats) from the liver, where bile is produced, to the gallbladder, where it is stored, and to the small intestine, where it aids in digestion. Primary sclerosing cholangitis occurs because of inflammation in the bile ducts (cholangitis) that leads to scarring (sclerosis) and narrowing of the ducts. As a result, bile cannot be released to the gallbladder and small intestine, and it builds up in the liver.
Video picks for Genetic conditionsVideo library
Description
Primary sclerosing cholangitis is a condition that affects the bile ducts. These ducts carry bile (a fluid that helps to digest fats) from the liver, where bile is produced, to the gallbladder, where it is stored, and to the small intestine, where it aids in digestion. Primary sclerosing cholangitis occurs because of inflammation in the bile ducts (cholangitis) that leads to scarring (sclerosis) and narrowing of the ducts. As a result, bile cannot be released to the gallbladder and small intestine, and it builds up in the liver.
Primary sclerosing cholangitis is usually diagnosed around age 40, and for unknown reasons, it affects men twice as often as women. Many people have no signs or symptoms of the condition when they are diagnosed, but routine blood tests reveal liver problems. When apparent, the earliest signs and symptoms of primary sclerosing cholangitis include extreme tiredness (fatigue), discomfort in the abdomen, and severe itchiness (pruritus). As the condition worsens, affected individuals may develop yellowing of the skin and whites of the eyes (jaundice) and an enlarged spleen (splenomegaly). Eventually, the buildup of bile damages the liver cells, causing chronic liver disease (cirrhosis) and liver failure. Without bile available to digest them, fats pass through the body. As a result, weight loss and shortages of vitamins that are absorbed with and stored in fats (fat-soluble vitamins) can occur. A fat-soluble vitamin called vitamin D helps absorb calcium and helps bones harden, and lack of this vitamin can cause thinning of the bones (osteoporosis) in people with primary sclerosing cholangitis.
Primary sclerosing cholangitis is often associated with another condition called inflammatory bowel disease, which is characterised by inflammation of the intestines that causes open sores (ulcers) in the intestines and abdominal pain. However, the reason for this link is unclear. Approximately 70 percent of people with primary sclerosing cholangitis have inflammatory bowel disease, most commonly a form of the condition known as ulcerative colitis. In addition, people with primary sclerosing cholangitis are more likely to have an autoimmune disorder, such as type 1 diabetes, celiac disease, or thyroid disease, than people without the condition. Autoimmune disorders occur when the immune system malfunctions and attacks the body's tissues and organs. People with primary sclerosing cholangitis also have an increased risk of developing cancer, particularly cancer of the bile ducts (cholangiocarcinoma).
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Other names
PSC
Sclerosing cholangitis
Patient picks for Genetic conditions

Digestive health
Primary sclerosing cholangitis
Primary sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage any complications which may occur. The outlook for people with primary sclerosing cholangitis can be very variable.
by Dr Colin Tidy, MRCGP

Digestive health
Primary biliary cholangitis
Primary biliary cholangitis (PBC) is a condition that slowly damages the bile ducts in your liver, leading to liver damage and, sometimes, liver scarring (cirrhosis).
by Dr Hayley Willacy, FRCGP

Cancer
Primary liver cancer
In primary liver cancer the cancer starts in the liver. In secondary liver cancer, the cancer spreads from another part of the body to the liver. Primary liver cancer is uncommon in the UK but is common in other parts of the world. In the UK, most cases develop as a complication of scarring of the liver (cirrhosis). In general the outlook is poor. Surgery to remove the cancer is an option in a small number of cases and, if it is possible, gives the best chance of a cure.
by Dr Toni Hazell, FRCGP

Children's health
1 in 5 children starting primary school are not fully protected against serious illnesses
Around 1 in 5 children going back to school are not protected against several serious illnesses. Read here about why UK Health Security Agency (UKHSA) and NHS England urge you to check your child’s vaccination record and catch up on any missed jabs, and what illnesses the vaccinations protect against.
by Lawrence Higgins

Oral and dental care
Primary cold sore infection
Your first (primary) infection with the cold sore virus can seem different to the repeated (recurring) cold sores which many people have. There may be no symptoms but sometimes there can be a significant infection of your mouth. Treatment aims to ease symptoms while the infection gradually settles over 1-3 weeks.
by Dr Philippa Vincent, MRCGP

Cancer
Primary bone cancer
Primary bone cancer occurs where a cancer originates in a bone. It is a rare type of cancer. There are several different types. Treatments which may be considered include surgery, chemotherapy and radiotherapy. The type of treatment used and the outlook depend on various factors including the type, site and stage of the cancer.
by Dr Rosalyn Adleman, MRCGP
Related patient information and medicines

Patient information leaflet
Primary sclerosing cholangitis
Primary sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Primary sclerosing cholangitis (PSC) is a rare condition that affects the bile ducts and liver..

Patient information leaflet
Primary biliary cholangitis
Primary biliary cholangitis (PBC) is a condition that slowly damages the bile ducts in your liver, leading to liver damage and, sometimes, liver scarring (cirrhosis). Is primary biliary cholangitis the same as primary sclerosing cholangitis. Primary biliary cholangitis (PB... For information on PSC, see the separate leaflet called Primary.

Patient information leaflet
Jaundice
Conditions affecting the tiny bile ducts If ... A backlog of bile (which contains bilirubin) then spills into the bloodstream. Various conditions can affect or damage the bile ducts in this way, for example, primary biliary cirrhosis Primary biliary cholangitis or primary sclerosing cholangitis Primary sclerosing cholangitis. It can also occur as.

Patient information leaflet
Cirrhosis
In autoimmune hepatitis, the immune system mak... Diseases that cause blockage of the bile ducts can cause back pressure and damage to the liver cells., for example, primary biliary cirrhosis Primary biliary cholangitis , sclerosing cholangitis Primary sclerosing cholangitis , and congenital problems of the bile ducts. Non-alcoholic.

Patient information leaflet
Ulcerative colitis
Ulcerative colitis is a disease where inflammation develops in the colon and the rectum (the large intestine). The most common symptom when the disease flares up is di... A type of arthritis affecting the spine (ankylosing spondylitis). A condition causing inflammation of the bile ducts of the liver (primary sclerosing cholangitis). A disease.

Patient information leaflet
Inflammatory bowel disease
Inflammatory Bowel Disease (IBD) is a term used to describe people who either have either of the two main types of IBD (Crohn's disease and ulcerative colitis). Increased risk of bowel cancer Bowel cancer (especially ulcerative colitis). IBD can also cause problems affecting other parts of the body - for example, arthritis, skin conditions, eye.
Further reading and references
- Primary sclerosing cholangitis; MedlinePlus, National Library of Medicine.
- Bergquist A, Lindberg G, Saarinen S, Broome U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol. 2005 Feb;42(2):252-6. doi: 10.1016/j.jhep.2004.10.011.
- Friedrich K, Rupp C, Hov JR, Steinebrunner N, Weiss KH, Stiehl A, Brune M, Schaefer PK, Schemmer P, Sauer P, Schirmacher P, Runz H, Karlsen TH, Stremmel W, Gotthardt DN. A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis. PLoS One. 2013;8(3):e58734. doi: 10.1371/journal.pone.0058734. Epub 2013 Mar 7.
- Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2010 Mar;138(3):1102-11. doi: 10.1053/j.gastro.2009.11.046. Epub 2009 Nov 26.
- Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Bjornsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M, Porte RJ, Holm K, Gieger C, Wichmann HE, Stokkers P, Ponsioen CY, Runz H, Stiehl A, Wijmenga C, Sterneck M, Vermeire S, Beuers U, Villunger A, Schrumpf E, Lazaridis KN, Manns MP, Schreiber S, Karlsen TH. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet. 2011 Jan;43(1):17-9. doi: 10.1038/ng.728. Epub 2010 Dec 12.
- Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):611-9. doi: 10.1038/nrgastro.2010.155. Epub 2010 Oct 12.
- Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis. 2003 Aug;35(8):571-6. doi: 10.1016/s1590-8658(03)00274-3.
- Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 1999 May;53(5):459-69. doi: 10.1034/j.1399-0039.1999.530502.x.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

